(2-METHOXYPHENYL)(4-METHYLPIPERAZIN-1-YL)METHANONE, 95.0%, 250mg

n-Octadecyldimethylmethoxysilane, 92%, 100g

2H-1,2,4-Triazole-3-carboxamide, 95.0%, 100g

4-Amino-3-hydroxybenzoic acid, 97.0%, 5g

2-(2,4-Dichlorophenoxy)ethanol, 95.0%, 5g

Polyethylenimine, ethylenediamine branched average Mw ~800 by LS, average Mn ~600 by GPC, 99.0%, 5g

Nonadeca-4,6-diyn-1-ol, 95%, 500mg

N,N,2-Trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 25g

4-Bromo-2,3,5,6-tetrafluorobenzaldehyde, 95.0%, 250mg

3-(Piperazin-1-yl)benzoic acid hydrochloride, 97.0%, 100mg

2,8-DIAZASPIRO[4.5]DECANE-1,3-DIONE HCL, 95.0%, 10g

2,6-Difluoro-4-methoxybenzoic acid, 95.0%, 10g

GC capillary column ROTI®Cap-5, 15 m, 0.32 mm, 5.00 µm, 1 Piece(s)